K. Brill

发表

Investigation of the influence of two low-dose monophasic oral contraceptives containing 20 micrograms ethinylestradiol/75 micrograms gestodene and 30 micrograms ethinylestradiol/75 micrograms gestodene, on lipid metabolism in an open randomized trial.

U. Beisiegel, F. Leidenberger, K. Brill, 1996, Contraception.

Comparison of serum ethinyl estradiol, sex-hormone-binding globulin, corticoid-binding globulin and cortisol levels in women using two low-dose combined oral contraceptives.

M. Hümpel, W. Kuhnz, R. Heithecker, 1990, Hormone research.

The influence of the dose of ethinylestradiol in oral contraceptives on follicle growth.

E. Kustra, J. Schnitker, A. Teichmann, 1995, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

The influence of different modern low-dose oral contraceptives on intermenstrual bleeding.

J. Schnitker, M. Albring, K. Brill, 1991 .

Minimizing the Problem of Poor Compliance in Adolescents Clinical Experience with a Modern Low‐Dose Gestodene‐Containing Oral Contraceptive

K. Brill, 1997, Annals of the New York Academy of Sciences.

Clinical experience with a modern low-dose gestodene-containing oral contraceptive in adolescents

J. Schnitker, M. Albring, K. Brill, 1994, Advances in contraception : the official journal of the Society for the Advancement of Contraception.

Inhibition of ovulation by an oral contraceptive containing 100 μg levonorgestrel in combination with 20 μg ethinylestradiol

W. Feichtinger, J. Spona, C. Kindermann, 1996 .

Clinical acceptability of monophasic gestodene.

B. Düsterberg, K. Brill, 1990, American journal of obstetrics and gynecology.

Large observational trial of a new low-dose oral contraceptive containing 20 μg ethinylestradiol and 100 μg levonorgestrel (Miranovar`) in Germany

R. Turck, K. Brill, R. Bannemerschult, 1999 .

A multicenter, uncontrolled clinical investigation of the contraceptive efficacy, cycle control, and safety of a new low dose oral contraceptive containing 20 μg ethinyl estradiol and 100 μg levonorgestrel over six treatment cycles

J. Hanker, P. Fox, M. Albring, 1997 .

Large observational trial of a new low-dose oral contraceptive containing 20 micrograms ethinylestradiol and 100 micrograms levonorgestrel (Miranova) in Germany.

R. Turck, K. Brill, R. Bannemerschult, 1999, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

O697 THE INTERNATIONAL CONTRACEPTIVE ACCESS (ICA) FOUNDATION – LESSONS FOR INCREASING INTERNATIONAL ACCESS TO THE LNG IUS

J. Townsend, K. Brill, 2012 .

Clinical experience with a modern low-dose oral contraceptive in almost 100,000 users.

J. Schnitker, T. Norpoth, M. Albring, 1991, Contraception.

The efficacy of oral cyproterone acetate in combination with ethinyloestradiol in acne tarda of the facial type

H. Gollnick, M. Albring, K. Brill, 1998 .

Clinical experience with a low-dose oral contraceptive containing gestodene.

B. Düsterberg, K. Brill, 1990, Advances in contraception : the official journal of the Society for the Advancement of Contraception.

Long-term experience with a low-dose oral contraceptive.

J. Schnitker, M. Albring, K. Brill, 1990, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Gestodene and desogestrel do not have a different influence on concentration profiles of ethinylestradiol in women taking oral contraceptives--results of isotope dilution mass spectrometry measurements.

F. Bidlingmaier, L. Siekmann, M. Albring, 1998, European journal of endocrinology.

Inhibition of ovulation by an oral contraceptive containing 100 micrograms levonorgestrel in combination with 20 micrograms ethinylestradiol.

W. Feichtinger, J. Spona, C. Kindermann, 1996, Contraception.